Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Steffel

Showing results (181-190 of 204) with videos related to

Pageof 21
Sort By:
Journal of Clinical Medicine|September 10, 2021
High Incidence of Inappropriate Alarms in Patients with Wearable Cardioverter-Defibrillators: Findings from the Swiss WCD RegistryBoldizsar Kovacs, Haran Burri, Andres Buehler, et al.
Heart Rhythm|October 24, 2024
Lateral QRS amplitude is independently associated with outcome after cardiac resynchronization therapy: Advancing patient selection?Sander Trenson, Peter C Kahr, Judith M Schwaiger, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 14, 2020
Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe studyJoris R de Groot, Thomas W Weiss, Peter Kelly, et al.
The American Journal of Medicine|November 2, 2023
Clinical Outcomes in Older Patients with Atrial Fibrillation: Insights from the GARFIELD-AF RegistrySamuel Z Goldhaber, Jean-Pierre Bassand, A John Camm, et al.
Circulation|January 24, 2024
Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial FibrillationSiddharth M Patel, Eugene Braunwald, Jan Steffel, et al.
Journal of the American College of Cardiology|August 6, 2025
Outcomes in Older Patients After Switching to a Newer Anticoagulant or Remaining on Warfarin: The COMBINE-AF SubstudyAndre M Nicolau, Robert P Giugliano, Andre Zimerman, et al.
Swiss Medical Weekly|October 9, 2020
Use of the wearable cardioverter-defibrillator - the Swiss experienceBoldizsar Kovacs, Sven Reek, Christian Sticherling, et al.
Circulation. Cardiovascular Quality and Outcomes|February 26, 2015
Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial FibrillationGregory Y H Lip, Sophie K Rushton-Smith, Samuel Z Goldhaber, et al.
Journal of Thrombosis and Haemostasis : JTH|February 7, 2026
Surgical and Procedural Bleed Risk Stratification for Anticoagulated Patients Undergoing Planned Surgery: Guidance from the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and HemostasisJoseph R Shaw, Jameel Abdulrehman, Steffan Frosi Stella, et al.
American Heart Journal|May 26, 2019
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AFSylvia Haas, A John Camm, Jean-Pierre Bassand, et al.
Pageof 21

Showing results (181-190 of 204) with videos related to

Sort By:
Pageof 21
Journal of Clinical Medicine|September 10, 2021
High Incidence of Inappropriate Alarms in Patients with Wearable Cardioverter-Defibrillators: Findings from the Swiss WCD RegistryBoldizsar Kovacs, Haran Burri, Andres Buehler, et al.
Heart Rhythm|October 24, 2024
Lateral QRS amplitude is independently associated with outcome after cardiac resynchronization therapy: Advancing patient selection?Sander Trenson, Peter C Kahr, Judith M Schwaiger, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 14, 2020
Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe studyJoris R de Groot, Thomas W Weiss, Peter Kelly, et al.
The American Journal of Medicine|November 2, 2023
Clinical Outcomes in Older Patients with Atrial Fibrillation: Insights from the GARFIELD-AF RegistrySamuel Z Goldhaber, Jean-Pierre Bassand, A John Camm, et al.
Circulation|January 24, 2024
Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial FibrillationSiddharth M Patel, Eugene Braunwald, Jan Steffel, et al.
Journal of the American College of Cardiology|August 6, 2025
Outcomes in Older Patients After Switching to a Newer Anticoagulant or Remaining on Warfarin: The COMBINE-AF SubstudyAndre M Nicolau, Robert P Giugliano, Andre Zimerman, et al.
Swiss Medical Weekly|October 9, 2020
Use of the wearable cardioverter-defibrillator - the Swiss experienceBoldizsar Kovacs, Sven Reek, Christian Sticherling, et al.
Circulation. Cardiovascular Quality and Outcomes|February 26, 2015
Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial FibrillationGregory Y H Lip, Sophie K Rushton-Smith, Samuel Z Goldhaber, et al.
Journal of Thrombosis and Haemostasis : JTH|February 7, 2026
Surgical and Procedural Bleed Risk Stratification for Anticoagulated Patients Undergoing Planned Surgery: Guidance from the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and HemostasisJoseph R Shaw, Jameel Abdulrehman, Steffan Frosi Stella, et al.
American Heart Journal|May 26, 2019
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AFSylvia Haas, A John Camm, Jean-Pierre Bassand, et al.
Pageof 21